Cardiac Resynchronization Therapy

1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Stereotaxis
StereotaxisST.LOUIS, MO
1 program
1
Bi-ventricular lead placementPhase 41 trial
Active Trials
NCT00370474Terminated27Est. Sep 2006
Abbott
AbbottABBOTT PARK, IL
1 program
MPP + SyncAVN/A1 trial
Active Trials
NCT06444386Completed30Est. Apr 2024
EBR Systems
EBR SystemsSUNNYVALE, CA
1 program
WiCS-LV SystemN/A1 trial
Active Trials
NCT02610673Active Not Recruiting100Est. Jun 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
StereotaxisBi-ventricular lead placement
AbbottMPP + SyncAV
EBR SystemsWiCS-LV System

Clinical Trials (3)

Total enrollment: 157 patients across 3 trials

NCT00370474StereotaxisBi-ventricular lead placement

MAGNET CRT Feasibility - Efficiency of LV Lead Placement Comparing Conventional vs. Magnetic Guidance

Start: Jun 2006Est. completion: Sep 200627 patients
Phase 4Terminated
NCT06444386AbbottMPP + SyncAV

ECGi of SyncAV With MultiPoint Pacing

Start: Sep 2021Est. completion: Apr 202430 patients
N/ACompleted
NCT02610673EBR SystemsWiCS-LV System

WiCS-LV Post Market Surveillance Registry

Start: Feb 2016Est. completion: Jun 2027100 patients
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space